Evidence map›Paper›PMID 19304673›Full record

ReviewArteriosclerosis, thrombosis, and vascular biology2009

Inflammation imaging in atherosclerosis.

James H F Rudd, Fabien Hyafil, Zahi A Fayad

Abstract readReview
In one paragraph

Review in Arteriosclerosis, thrombosis, and vascular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Trial
  3. [EJNMMI research · 2026
    Review
  4. Article
  5. Peptide Receptor Radionuclide Therapy UsingDiagnostics (Basel, Switzerland) · 2024
    Article
  6. Accuracy of PET quantification in [Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  7. Review
  8. Standardization and quantification is a key to the future of atherosclerosis FDG PET/CT imaging.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  9. Optical Biosensors for Virus Detection: Prospects for SARS-CoV-2/COVID-19.Chembiochem : a European journal of chemical biology · 2021
    Review
  10. Article
  11. [ACS medicinal chemistry letters · 2020
    Article
  12. Magnetic resonance imaging for pathobiological assessment and interventional treatment of the coronary arteries.European heart journal supplements : journal of the European Society of Cardiology · 2020
    Article
  13. Article
  14. Imaging inflammation in atherosclerotic plaques: Just make it easy!Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019
    Article
  15. Development of an inflammation imaging tracer,Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

James H F RuddDivision of Cardiovascular Medicine, Cambridge University, UK. jhfr2@cam.ac.uk
Fabien Hyafil
Zahi A Fayad

Funding

MR/PET Imaging of coronary atherosclerosisR01HL071021 · NHLBI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI FAYAD, ZAHI A. · 2002 to 2019
$7.8M
Theranostic HDL nanoparticles for inflammatory macrophages in atherosclerosisR01EB009638 · NIBIB · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FAYAD, ZAHI A. · 2009 to 2016
$4.6M
Nanoparticles for Molecular MRI of AtherosclerosisR01HL078667 · NHLBI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI FAYAD, ZAHI A. · 2004 to 2008
$2.5M
British Heart FoundationNHLBI NIH HHS R01 HL071021NHLBI NIH HHS R01 HL078667NIBIB NIH HHS R01 EB009638
6 · The paper itself

Abstract

Inflammation is important at many stages of atherosclerotic plaque development. We highlight several imaging modalities that can quantify the degree of plaque inflammation noninvasively. Imaging of this type might allow testing of novel antiatherosclerosis drugs, identification of patients at risk of plaque rupture, and deeper insight into the biology of the disease. The imaging modalities are discussed in relation to their potential use in these areas.

Indexed as

Contrast MediaAtherosclerosisDiagnostic ImagingHumansInflammationContrast Media

Identifiers

PMID19304673
PMCPMC2836586

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.